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ABSTRACT 
Recently, there has been increasing focus toward the development of small molecules designed to 
target a specific sequences of double stranded DNA for therapeutic purposes1. Minor groove 
binding compounds have been shown to be capable of selectivity target GC sites in AT tract DNA2. 
In this research, binding selectivity was investigated using absorption, fluorescence and circular 
dichroic properties of selected DB minor groove binders in the presence of two unique DNA 
sequences. Further insight was gained by comparing the electrostatic potential maps and optimized 
structures of the compounds of interest. Using the results presented, potential selective minor 
groove binders can be selected for further investigation and kinetic studies.  
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1. Introduction 
1.1 Minor Groove Binding Compounds 
 Errors in gene expression are responsible for numerous common human diseases1, 3.  A 
comprehensive understanding of the biochemistry helps to identify irregularities in genetic 
expression pathways. Beginning at DNA transcription and ending with protein transcription, each 
step along this pathway is a potential target for therapeutic agents that can identify abnormalities. 
Recently, there has been increasing amount of focus toward the development of molecules 
designed to target a specific sequence of DNA at the beginning of this process4.  These molecules 
then have the ability to influence gene expression.     
 Chemical agents that target double-stranded DNA can do so by two different methods of 
interaction (Figure 1). Intercalators, such as ethidium bromide, bind to target DNA by stacking 
between the planar base pairs in DNA. Distinct from intercalation, groove binders target the major 
or minor grove of the DNA helix.  In B-form DNA, the major groove is wider and deeper than the 
minor groove making it the preferred target for DNA binding proteins5. This leaves the narrower 
minor groove available for interaction with small molecules.  
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(a) (b)  
Figure 1. (a) Possible ways in which molecules can interact with DNA. Intercalation by polycyclic aromatic 
ring structures shown in red. Major groove binding agents, such as proteins, shown in green.  Minor groove 
binding small molecultes represented in light blue6. (b) Major and minor groove sides of DNA base pairings 
with Watson-Crick hydrogen bonds represented by dashed lines7. 
 
Minor groove binding compounds are typically small molecules that have an ability to 
adapt to the native curvature of DNA backbone7. Generally, these small molecules are 
heterocyclic, aromatic structures that form hydrogen bonds with DNA base pairs7. Molecules that 
align favorably will also form van der Waals interactions with the groove, furthering binding 
stability. Binding sequence selectivity is often attributed to these binding patterns. Classical minor 
groove binding molecules such as DAPI, distamycin and Hoechst 33258 (Figure 2) have 
historically have shown a preference for AT base pairs8. This is attributed to the higher electrostatic 
potential at AT rich regions, which aids in binding for cationic compounds such as the 
monocationic polyamide distamycin and the dicationic indole DAPI4,8. At GC steps, the amino 
group of guanines protrudes into the minor groove hindering favorable stabilizing van der Waals 
interactions6. 
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Figure 2. Structures of three classical DNA minor groove-binding compounds distamycin, DAPI, Hoechst 
332588. 
 
1.2 Molar Extinction Coefficients 
 Molar extinction coefficients, also known as molar absorptivity or molar attenuation 
coefficients, measure the strength of light absorption at a given wavelength. This intrinsic chemical 
property is determined by measuring absorbance using ultraviolet and visible light (UV/Vis) 
spectroscopy. The Beer-Lambert law allows the molar extinction coefficient to be calculated from 
experimental data. The Beer-Lambert law states that absorbance is equal to the concentration of a 
species multiplied by the path length of the cuvette and molar extinction coefficient9. This implies 
that the absorbance is directly proportion to both the path length of the cuvette and the 
concentration of the sample.  
𝐴 = 𝑐𝑙𝜖 
Equation 1. Beer-Lambert Law 
 In Equation 1, 𝑐, is the concentration of the sample, 𝑙, is the path length defined as the 
distance the light wave travels through the cuvette, while A, is the measured absorbance of the 
sample. The molar extinction coefficient, 𝜖, can be solved for from the previously defined 
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variables. Once the value of 𝜖 is solved for from a known concentration it can be used to determine 
an unknown concentration of a given chemical species9.  
1.3 Fluorescence Spectroscopy 
 Light emission can provide insight to properties that are different from those properties 
related to light absorption10. When a molecule enters an excited electric state, one electron occupies 
a higher energy level. In order for it to return to the lower energy ground state configuration, the 
absorbed energy has to be released either in the form of heat or light. Luminescence is the emission 
of light from a substance that does not produce heat when an electron becomes excited by the 
absorption of a photon. Species that luminesce can do so in two processes: fluorescence or 
phosphorescence. To return to the ground state energy level, one of three things may occur: (1) it 
can fall back to the ground state from the singlet state after internal conversion, resulting in 
fluorescence, (2) emit a photon, (3) or it can convert to triplet state by intersystem crossing11. In 
the triplet state scenario, the electron again has three possible paths: (i) it can fall back to the 
ground state, resulting in phosphoresce, (ii) emit a photon (iii) or undergo a non-radiative transition 
to the ground level. The various types of energy level transitions are depicted in the Jabłoński 
diagram (Figure 3)10,11.  
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Figure 3. Jabłoński diagram12 
 
 Three of the possible energy transfers do not result in luminescence. One such transfer is 
vibrational relaxation10,11. Vibrational relaxation, represented as black arrows in Figure 3, is the 
process by which energy is transferred to other vibrational levels as kinetic energy10,11. Internal 
conversion is another non-luminescent process by which the energy absorbed can be transferred 
to a lower energy level. It occurs when energy is transferred between overlapping vibrational and 
electronic energy levels and is depicted in the above Jabłoński diagram by the cyan arrow between 
S2 and S1 energy states. The final non-radiative energy conversion is an intersystem crossing. In 
this process, energy is transferred from a higher excited state to a lower excited state in conjunction 
with a change in spin orientation11. It is depicted as a cyan arrow between S1 and T1 in Figure 
3.This process is the rarest of all three non-radiative energy transfers and is referred to as 
“forbidden”11.  
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After intersystem crossing to the triplet state, an electron can return to the ground state by 
phosphorescence11. Intersystem crossing to the triplet state occurs extremely rarely because it 
requires changing the orientation of a spin so that the unpaired ground state electron and excited 
electron are symmetric11. This can occur in three separate ways in that the unpaired ground state 
electron and excited electron can both have spin up or spin down, or the sum of the paired spin 
states is symmetric. The observed emission rates are extremely slow for phosphorescence, on the 
order of 10-2 to 10-4 s11. Fluorescence, on the other hand, occurs after singlet state transitions. The 
spins of the unpaired ground state electron and excited electron remain antisymmetric and the 
emission is considered an “allowed” transition11. This type of transition happens rapidly, on the 
magnitude of 10-8 s for photon emission11. 
Fluorescence spectroscopy can be used for a number of biochemical applications including 
binding studies. The relative changes in fluorescence during a titration can indicate possible 
interactions occurring and both the binding affinity and kinetics can be calculated from this data11. 
Due to the highly conjugated nature of aromatic compounds and their ability to act as 
chromophores, fluorescence may readily occur after photon absorption; however, even if the 
compound of interest does not have intrinsic fluorescence, it can still be studied using fluorescence 
spectroscopy using a fluorescently labeled tag13. 
1.4 Circular Dichroism 
Due to their asymmetry, most biomolecules are natively optically active. Optical activity is 
also seen in many small molecules due to the presence of asymmetric carbon atoms and their 
interaction on conjugated ring systems11. Optical activity can be measured in two ways, the optical 
rotatory dispersion (ORD) and the circular dichroism (CD). Passing a linearly polarized traverse 
wave through an asymmetric structure will cause the resultant wave to change in amplitude and 
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orientation in comparison to the incident wave10,11. The amplitude of the electric field is no longer 
restricted to the perpendicular plane of the propagation and it creates an elliptical screw axis11. The 
resultant ellipticity is measured as the arc tangent of the ratio of the minor axis to the major axis 
of the projected ellipse.  
The orientation of the ellipse is also an indicator of optical activity. As a result of the change 
in the amplitude, the elliptical screw axis is no longer parallel to the incident light. At the limit of 
optical absorption where the axis ratio approaches zero, the resultant wave is equivalent to plane 
polarized light. Thus, the measurement of the orientation of the ellipse corresponds to the optical 
rotation. This optical rotation is measured as a function of the wavelength is called optical rotary 
dispersion (ORD)11. The resultant electric field can be decomposed into the two components of 
circular polarization. This is useful to compare the differences in absorptions between left and right 
handed circularly polarized light. The difference between these two absorptions is called circular 
dichroism (CD)11. The left or right-handed circularly polarized wave that is absorbed more by the 
optically active sample will display an increase in amplitude relative to its counterpart. This results 
in an elliptically polarized light. The degree of ellipticity is calculated by the CD 
spectrophotometer and then displayed as a function of wavelength10,11.   
Circular dichroism spectroscopy depends on producing circularly polarized light. Light waves 
are transverse waves comprised of electric and magnetic fields that oscillate perpendicular to the 
direction of travel. Polarization of transverse waves refers to the polarization of the electric 
component only10.  When the electric and magnetic fields are oscillating together with equivalent 
amplitude but differing in phase by 90, the resultant light wave will be circularly polarized. As 
circular polarized light propagates along the direction of travel, the result is an electric field 
rotating directionally but not changing in strength11. By passing linearly polarized light through a 
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quarter-wave plate at an angle of 45 to the optic axis this rotation can be achieved14. The electric 
vector then emerges at an angle of 45 to the axis of propagation. It can be split into two 
components, the horizontal and vertical direction. The light then passes through a quarter-wave 
retarder. When the horizontal component is retarded one-quarter of a wave relative to vertical 
component, the resultant wave is right circularly polarized14. When the vertical component is 
retarded one-quarter wave relative to the horizontal component the wave is left circularly 
polarized14.  
 
Figure 4. Image of circularly polarized light. The blue line represents the magnetic component of light while 
the green line represents the electric component. The red live indicates the circularly polarized light that 
occurs when the magnetic and electric waves are 90 out of phase15.    
 
CD and ORD spectroscopy are most often used to determine biomolecule secondary 
structures10,11. ORD can be used to determine chemical concentrations or to determine purity of 
the chiral ligand. Beta sheets and alpha helices in proteins show discrete and reproducible patterns 
in a CD spectrum while different DNA helical types also produce distinct patterns and thus 
resultant CDs can be compared in databases for structure determination16. CD spectroscopy is not 
limited to use in secondary structure determination. DNA binding studies have also been 
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conducted using CD to discover information such as binding affinities and/or types of 
interactions16.  
1.5 Computational Chemistry 
Although circular dichroism, fluorescence, UV-Vis spectroscopy provide critical 
information such as kinetics of binding, these methods are limited because they cannot provide 
atomistic detail. Computational chemistry is widely applied to biomolecular inquiries such as drug 
discovery, free energy prediction and protein folding17. It is ideally suited for a variety of 
chemically related investigations, such as small molecule binding, because the computational 
expenses and sampling concerns usually encountered with large biomolecular systems are 
diminished17. Molecular dynamics (MD) has been shown to be a promising tool in response to the 
increasing demand for greater detail in experimental results. Advances in MD studies have also 
aided in making this a reliable means for chemical inquiries. Molecular dynamics provides details 
both temporal and spatial evolution of systems based on Newtonian physics17.  
There are numerous methods to investigate the dynamics of biological systems. Each 
method depends on the potential energy function used therefore choosing the correct potential 
energy function is crucial to a successful simulation18. Each of these energy functions generally 
describes the bonded terms using Hooke’s Law, Newtonian Mechanics, and non-bonded terms by 
the Lennard-Jones Potential and Coulomb’s Law17. Each of these terms consists of a number of 
parameterized terms that are obtained from experimental results or quantum mechanical 
calculations of small molecules18.  
The set of parameters describing the potential energy function is called a force field. 
Choosing the appropriate force field is the first step in building a model for the system of interest. 
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Some of the most common force fields include AMBER ff99SB, CHARMM 27 and SYBYL17. 
These force fields include parameters for the most commonly encountered biological molecules 
including protein amino acids and nucleic acid bases.  
In the investigation of small molecules, many force fields are generally not sufficient to 
describe the ligand because the molecule has not been parameterized. In these cases, additional 
methods are necessary to parameterize the terms in the force field17. Quantum chemical methods 
can be employed to determine these parameters for later use in MD simulations. One of the benefits 
of quantum chemistry is that no prior knowledge is necessary to study the small molecule in 
question. The results from the quantum mechanical calculations are then compared to experimental 
data to gain further insight into energetics.   
As with all computational techniques, it is necessary to choose a method that can accurately 
reproduce known results while at the same time keep computational expenses at attainable levels. 
Quantum mechanical models such as Hartree-Fock, density functional theory and semi-empirical 
models are highly accurate, but generally extremely time consuming to run. Each of these methods 
seeks to solve the many-body Schrödinger equation. Historically, the solution to solving the 
quantum many-body system has been the Hartree-Fock equation19. In this approximation, the 
electrons are considered to be non-interactive. Therefore, the resultant Hamiltonian becomes 
separable and solvable20. Each electron is considered to be in its own molecular orbital, which 
moves in an average field of the other electrons19. Each of these orbitals is expressed in a so-called 
Slater Determinant20. This is a convenient form to express the orbitals because interchange of any 
of the elements of the determinant causes antisymmetry, which is the requirement of the 
Schrödinger equation20. The determinant is comprised of a set of functions that describes the 
molecular orbitals, called a basis set. The minimal basis set only contains functions required to 
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accommodate all the electrons in the atom while maintaining spherical symmetry and is called the 
STO-3G basis set18. There have been many expansions to this basis set including the split-valence 
Pople basis sets which use a set of Gaussian functions to describe the valence and outer shell 
electrons separately18. The most commonly used Gaussian basis set is the 6-31G* set which uses 
six Gaussian functions to describe the core orbitals, and the valence orbitals are split into three and 
one Gaussian functions. The star indicates that there are additional functions describing the 
polarizability of the d-orbitals of the molecule. Using this basis set and the Hartree-Fock 
approximation, fairly accurate quantum chemical predictions can be calculated including energy-
minimized geometries, electron potential surfaces and torsional energy profiles18. 
2. Purpose of Study 
Compounds that selectively target DNA have supplied clinically beneficial therapeutics for 
a variety of diseases ranging from African sleeping sickness to cancer. Minor groove binding drugs 
have advantages over intercalating agents due to their increased sequence specificity and lower 
levels of mutagenic effects. Although a variety of these compounds have been produced and are 
now in use as treatments, much more information is still needed regarding binding strategies and 
sequence selectivity.   
The research presented in this thesis has two principal objectives. First, the determination 
of absorption, fluorescence, and circular dichroic properties of selected minor groove binders in 
the presence of two DNA sequences in order to understand binding selectivity. The second aspect 
of the study is to perform computational calculations on the minor groove binding compounds to 
gain an understanding of their unbound conformations and electrostatics. Both spectroscopic and 
computational calculations will lead to further insight into the compound-DNA complex and 
binding mechanics.  
In order to better determine sequence specificities, two DNA sequences, 5’-AAAATTT-3’ 
(A4T3) and 5’-AAAGTTT-3’ (A3GT3), were studied. In addition to the two DNA sequences, 
three groups of minor groove binders were selected for additional investigation. Cationic minor 
groove binders have been shown to be successful therapeutics. They can readily enter the cell 
nucleus, target specific DNA sequences and work allosterically with gene-control proteins by 
targeting the minor groove. Using this knowledge as a starting point, the Boykin group at Georgia 
State University has synthesized numerous small molecules with additional heterocycles and 
functional groups as “linkers” in effort to increase selective targeting. Using data from previously 
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described spectroscopic techniques and computational calculations, minor groove binders can be 
modified to selectivity target AT regions or a single GC step in an AT tract. The core group of 
compounds in this study contains DB 2363, DB 2364, DB 2324 and DB 2368. Each of these 
potential groove binders is built around a central benzimidazole linked to ionic groups via one or 
more phenyl rings. The second category is comprised of DB 2309, DB 2325, DB 2327 and DB 
2328. These compounds have unique heterocycles incorporated as central moieties or linkers. The 
third group, DB 2326, DB 2351, DB 2348 and DB 2350, contains larger, symmetric potential 
groove binders all with the same symmetric components but with varying central linkers.  
DNA Sequences 
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Figure 5. (a) Two DNA sequences used for binding titrations. (b) Heterocyclic cationic compounds 
synthesized by the Boykin group at GSU. Category 1 compounds consist of a core benzimidazole with 
minor interior modifications. Category 2 compounds vary based upon their central moiety and incorporation 
of unique heterocycles. Category 3 contains large symmetric compounds with different joining groups. 
3. Methods 
3.1 Molecular Absorptivity 
Molar absorptivity coefficients (or extinction coefficient ) were obtained using a Cary 300 
Bio UV-Vis spectrophotometer by Varian. The extinction coefficient of a known concentration of 
a compound was determined from the absorbance at its maximum wavelength by using the Beer-
Lambert Law that states that the absorbance of a compound is directly proportional to the 
concentration of the absorbing species and the cuvette pathlength.  
𝐴 = 𝜀𝑐𝑙     
3.2 Fluorescence Spectroscopy 
 Previously determined maximum absorption wavelengths from UV-Vis spectroscopy were 
used for each compound in fluorescence titration analyses (Figure 7). Each compound was titrated 
with both 5’-AAAATTT-3’ and 5’-AAAGTTT-3’ DNA sequences in a 50 mM Tris-HCl, 100 mM 
NaCl, 1mM EDTA buffer, at pH 7.45. All twelve small molecules were titrated at a concentration 
of 1µM in a 1cm quartz cuvette for baseline reference. Compound was then titrated into the sample 
solution to give concentration ratios ranging from 0.2:1 to 1:1 of DNA to compound (DNA:ligand). 
Excitation and emissions slit widths varied among chemical compounds. All data was graphed and 
analyzed using Origin software21.   
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Table 1 Fluorescence spectroscopy parameters for each DB compound. Excitation wavelengths, excitation 
and emission silt widths for all compounds shown below.   
Compound max (nm) Excitation silt width (nm) Emission silt width (nm) 
DB 2324 334 2.5 5 
DB 2363 314 2.5 2.5 
DB 2364 302 2.5 5 
DB 2368 350 10 5 
Compound max (nm) Excitation silt width (nm) Emission silt width (nm) 
DB 2309 323 2.5 2.5 
DB 2325 388 10 5 
DB 2327 345 2.5 2.5 
DB 2328 325 5 5 
Compound max (nm) Excitation silt width (nm) Emission silt width (nm) 
DB 2326 306 5 5 
DB 2348 305 10 10 
DB 2350 304 5 5 
DB 2351 302 10 5 
 
 
Figure 6. Spectral representation of a molecule excited at one wavelength (i.e. absorbance) represented by 
the blue line and emission (i.e. fluorescence) represented by the red line. Peak maxima show where the 
hypothetical compound best absorbs and emits light. The emission curve is at a lower energy level and, 
thus, at a higher wavelength than the absorbance curve22.   
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3.3 Circular Dichroism 
 CD was conducted using a Jasco J-810 spectrophotometer using a 1 cm quartz cuvette. A 
solution of 3 µM of DNA in a 50 mM Tris-HCl, 100 mM NaCl, 1mM EDTA buffer at pH 7.45 
was used in all titration scans. The compound of interest was then added beginning with a 0.4:1 
concentration ratio (ligand:DNA) and increased by increments until 3.2:1 (ligand:DNA) ratio was 
met. The process was repeat for both 5’-AAAATTT-3’ and 5’-AAAGTTT-3’ DNA sequences. 
Wavelengths ranged between 650 to 220 nm with a response speed of 1 s and a scanning speed of 
50 nm/min, reproduced in triplicate and then averaged. All data was graphed and analyzed using 
Origin software21.   
3.4 Molecular Modeling 
 Electrostatic potential maps were calculated from the optimized structures using Spartan 
‘14 software package (Wavefunction Inc., Irvine, CA)23. Final geometry optimizations were 
calculated using the Hartree-Fock method and 6-31G* basis set. 
 
  
4. Results 
4.1 Molar Extinction Coefficients 
Table 2. Molar extinction coefficients are listed for all compounds. Wavelength of maximum absorption 
for each DB compound is displayed. 
Compound Extinction Coefficient (L/M*cm)) max (nm) 
DB 2324 3.2 x 104 334 
DB 2363 3.0 x 104 314 
DB 2364 2.0 x 104 302 
DB 2368 4.6 x 104 350 
Compound Extinction Coefficient (L/M*cm)) max (nm) 
DB 2309 3.3 x 104 323 
DB 2325 3.6 x 104 388 
DB 2327 6.0 x 104 345 
DB 2328 3.7 x 104 325 
Compound Extinction Coefficient (L/M*cm)) max (nm) 
DB 2326 3.1 x 104 306 
DB 2348 3.4 x 104 305 
DB 2350 2.8 x 104 304 
DB 2351 1.9 x 104 302 
 
 
 
 
 
 
 
 
 
4.2 Category 1 Compounds 
4.2.1 Molecular Modeling 
 
Figure 7. Ball and stick models along with their electrostatic potential maps generated using Spartan ’14. 
Hartree-Fock method with a 6-31G* basis was used to determine minimized structures. Electrostatic 
potential surfaces are mapped using calculated values. Blue regions represent areas of positive electrostatic 
potential whereas areas with negative electrostatics are displayed as red. Green represents hydrophobic 
regions of the compound. Compounds (from top to bottom) DB 2324, DB 2363, DB 2364, DB 2368 are 
shown. 
4.2.2 Fluorescence Titrations 
DB 2324 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 8. (a) Fluorescence titration of 1µM DB 2324 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 334 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 5 nm. 
The black line indicates free compound, while the blue lines represent a 1:1 ratio of 5’-AAAGTTT-3’. The 
fluorescence intensity showed both a steady decrease in intensity and blue shift in wavelength maximum. 
(b) Chemical structure of DB 2324.  
DB 2324 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 9. (a) Fluorescence titration of a 1µM DB 2324 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 334 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue lines shows a 1:1 ratio of 5’-AAAGTTT-3’. 
Complete fluorescence quenching appears at 1:1 binding. (b) Chemical structure of DB 2324.  
DB 2363 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 10. (a) Fluorescence titration of 1µM DB 2363 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 314 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 2.5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAATTT-3’. DB 2363 
showed a steady decrease in fluorescence upon binding to DNA. (b) Chemical structure of DB 2363. 
DB 2363 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 11. (a) Fluorescence titration of 1µM DB 2363 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 314 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 2.5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. DB 2363 
showed a steady decrease in fluorescence upon binding to 5’-AAAGTTT-3’. (b) Chemical structure of DB 
2363.  
DB 2364 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 12. (a) Fluorescence titration of 1µM DB 2364 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 302 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAATTT-3’. With an 
increase in DNA concentration, fluorescence intensity decreased. (b) Chemical structure of DB 2364. 
DB 2364 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 13: (a) Fluorescence titration of 1µM DB 2364 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 302 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 5 nm. 
The black line indicates free compounds while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. With 
an increase in DNA concentrations, fluorescence intensity decreased. (b) Chemical structure of DB 2364. 
DB 2368 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 14. (a) Fluorescence titration of 1µM DB 2368 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 350 nm 
was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAATTT-3’. DB 2368 
showed little inherent fluorescence. Additions of DNA up to a 0.4:1 ratio displayed an increase in 
fluorescence; however, the fluorescence intensity began to decrease following higher concentrations of 
DNA to compound. (b) Chemical structure of DB 2368.  
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DB 2368 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 15. (a) Fluorescence titration of 1µM DB 2368 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 350 nm 
was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. DB 2368 
showed low inherent fluorescence. Initial additions of DNA (up to 0.6:1) displayed an increase in 
fluorescence; however, the fluorescence began to decrease starting at a 0.8:1 DNA to compound ratio. (b) 
Chemical structure of DB 2368. 
4.2.3 Circular Dichroism  
DB 2324 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 16. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2324. The titration was 
carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. DNA concentration was 
3 µM. Changes in the regions past 300 nm indicate minor groove binding. Regions before 300 nm suggest 
that the conformation of DNA had little change. (b) Chemical structure of DB 2324 is shown below. 
DB 2324 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 17. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2324. The titration was 
carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. DNA concentration was 
3 µM. Changes in the regions past 300 nm indicate minor groove binding. The large changes in the regions 
prior to 300 nm suggest that DB 2324 is changing the conformation of the DNA when binding occurs. (b) 
Chemical structure of DB2324. 
DB 2363 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 18. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2363. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 
7.4. Minor groove binding is shown in the 300 to 350 nm region for DB 2363. Microstructural changes in 
the DNA may occur in the region below 300 nm as a result of minor groove binding. (b) Chemical structure 
of DB 2363. 
DB 2363 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 19. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2363. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 
7.4. Minor groove binding is shown in the region of 300 to 350 nm for DB 2363. Microstructural changes 
in the DNA conformation may occur upon binding DB 2363 based on spectral changes in the region below 
300 nm. (b) Chemical structure of DB 2363. 
DB2364 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 20. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2364. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 
7.4. Little to no changes occur in the 300 to 350 nm region indicating DB 2363 binds weakly, if at all, in 
the minor groove. Microstructural changes may occur in the DNA conformation upon binding DB 2364 in 
the region below 300 nm. (b) Chemical structure of DB 2364. 
DB2364 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 21. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2364. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 
7.4. Very small changes in the 300 to 350 nm region indicate that DB 2363 does not bind in the minor 
groove. Microstructural changes may occur in the DNA conformation in the region below 300 nm. (b) 
Chemical structure of DB 2364. 
DB 2368 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 22. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2368. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 
7.4. Fluctuations in the 300 to 350 nm region indicate that DB 2368 binds to the minor groove. Large 
structural changes occur in the DNA conformation as shown in the spectrum below 300 nm. Peaks shown 
above 350 nm are due to the Cotton effect. (b) Chemical structure of DB 2368. 
DB 2368 Titrated with 5’-AAAGTTT-3’  
 
 
Figure 23. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2368. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 
7.4.  Fluctuations in the 300 to 350 nm region indicate that DB 2368 binds to the minor groove. 
Microstructural changes may occur in the DNA conformation as shown in the spectrum below 300 nm. The 
maximum wavelength of absorption for DB 2368 was at 388 nm. Peaks shown above the 350 nm are due 
to the Cotton effect. (b) Chemical structure of DB 2368. 
4.3 Category 2 Compounds 
4.3.1 Molecular Modeling 
 
 
Figure 24. Ball and stick models along with their electrostatic potential maps generated using Spartan ’14. 
Hartree-Fock calculations with a 6-31G* basis were used to determine minimized structures. Electrostatic 
potential surfaces are mapped using calculated values. Blue regions represent an area of positive 
electrostatic potential whereas areas with negative electrostatic interaction are displayed as red. Green areas 
indicate hydrophobic regions of the compound. Compounds (top to bottom) DB 2309, DB 2325, DB 2327, 
DB 2328 are shown. 
4.3.2 Fluorescence Spectroscopy  
DB 2309 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 25. (a) Fluorescence titration of 1µM DB 2309 with 5’-AAAATTT-3’ The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4.An excitation wavelength of 334 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 2.5 nm. 
The black line indicates free compound while the blue line shows a concentration ratio of 1:1 for 5’-
AAAATTT-3’. Addition of DNA showed a steady decrease in fluorescence. (b) Chemical structure of DB 
2309.  
DB 2309 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 26. (a) Fluorescence titration of 1µM DB 2309 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4.An excitation wavelength of 334 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 2.5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. Each 
addition of DNA displayed a decrease in fluorescence intensity. (b) Chemical structure of DB 2309.  
DB 2325 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 27. (a) Fluorescence titration of 1µM DB 2325 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 388 nm 
was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAATTT-3’. Once a 
0.4:1 concentration ratio of DNA to compound was met, a nominal increase in fluorescence intensity was 
reached to 0.8:1; however, a slight decrease in fluorescence intensity was observed at a 1:1 ratio. (b) 
Chemical structure of DB 2325.  
DB 2325 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 28. (a) Fluorescence titration of 1µM DB 2325 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 388 nm 
was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. Initial 
additions of DNA resulted in increasing fluorescence intensities. Once a 0.4:1 ratio of DNA to compound 
was met, the fluorescence intensity experienced a nominal increase with each additional aliquot added until 
a 1:1 ratio, which showed a decrease in fluorescence. (b) Chemical structure of DB 2325. 
DB 2327 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 29. (a) Fluorescence titration of 1µM DB 2327 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 345 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 2.5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAATTT-3’. Initial 
additions resulted in increases in fluorescent intensities. Fluorescence intensities increased, until a 1:1 ratio 
of DNA to compound was met which resulted in a decrease in intensity. (b) Chemical structure of DB 2327.  
DB 2327 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 30. (a) Fluorescence titration of 1µM DB 2327 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 345 nm 
was used. The titration was run with an excitation slit width of 2.5 nm and an emission slit width of 2.5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. Upon 
addition of DNA, a dramatic increase in fluorescence intensity was observed. Fluorescence intensities 
increased until a 0.6:1 ratio of DNA to compound was met after which decreases were observed. (b) 
Chemical structure of DB 2327.  
DB 2328 Titrated with 5’-AAAATTT-3’ 
  
 
Figure 31. (a) Fluorescence titration of 1µM DB 2328 with 5’-AAAATTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 325 nm 
was used. The titration was run with an excitation slit width of 5 nm and an emission slit width of 5 nm. 
The black line indicates free compounds while the blue line shows a 1:1 ratio of 5’-AAAATTT-3’. 
Fluorescence intensity increased with each titration of DNA added. (b) Chemical structure of DB 2328. 
DB 2328 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 32. (a) Fluorescence titration of 1µM DB 2328 with 5’-AAAGTTT-3’. The titration was carried out 
in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 325 nm 
was used. The titration was run with an excitation slit width of 5 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. 
Fluorescence intensity steadily decreased with each additional aliquot of DNA. (b) Chemical structure of 
DB 2328. 
4.3.3 Circular Dichroism   
DB2309 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 33. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2309. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Very small changes in the 300 to 350 nm region indicate that DB 2309 is binding in the minor groove. 
Minor DNA microstructural changes may occur upon binding DB 2309 as shown below 300 nm. (b) 
Chemical structure of DB 2309. 
DB2309 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 34. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2309. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Very small changes in the 300 to 350 nm region indicate that DB 2309 is binding in the minor groove. 
DNA may experience some microstructural changes represented by the variations shown below 300 nm. 
(b) Chemical structure of DB 2309. 
DB2325 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 35. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2325. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Negatively induced rotation above 400 nm is indicative of intercalation. DNA microstructural changes 
may occur below 300 nm. (b) Chemical structure of DB 2325. 
DB 2325 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 36. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2325. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Negatively induced CD above 400 nm is indicative of intercalation. DNA microstructural changes may 
occur below 300 nm. (b) Chemical structure of DB 2325. 
DB 2327 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 37. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2327. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Large induced changes in the spectrum in the 300 to 350 nm region indicate DB 2327 is binding in the 
minor groove. Negatively induced CD may indicate a secondary intercalation-binding mode. DNA shows 
some microstructural changes represented by the increased CD shown below 300 nm. (b) Chemical 
structure of DB 2327. 
DB 2327 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 38. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2327. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Large induced CD changes in the 300-350 nm region indicate that DB 2327 is binding in the minor 
groove. Negative CD changes above 350 nm may indicate a secondary intercalation-binding mode. Positive 
induced CD in the region below 300 nm DNA suggests microstructural changes in the DNA. (b) Chemical 
structure of DB 2327. 
DB 2328 Titrated with 5’-AAAATTT-3’  
 
 
Figure 39. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2328. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Induced CD changes in the 300 nm region indicate binding to the minor groove. Variations below 300 
nm may suggest DNA experiences some microstructural changes. (b) Chemical structure of DB 2328. 
DB 2328 Titrated with 5’-AAAGTTT-3’  
 
 
Figure 40 (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2328. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Alterations near the 350 nm region suggest DB 2328 is binding in the minor groove. DNA may 
experience some microstructural changes upon binding as based on changes in CD below 300 nm. (b) 
Chemical structure of DB 2328. 
4.4 Category 3 Compounds 
4.4.1 Molecular Modeling 
 
 
Figure 41. Ball and stick models along with their electrostatic potential maps generated using Spartan ’14. 
Hartree-Fock method with a 6-31G* basis was used to calculate the minimized structure. Electrostatic 
potential surfaces are mapped using calculated values. Blue regions represent areas of positive electrostatic 
potential whereas areas with negative electrostatic interaction are displayed as red. Green indicates 
hydrophobic regions of the compound. Compounds (top to bottom) DB 2326, DB 2348, DB 2350, DB 
2351. 
4.4.2 Fluorescence Spectroscopy  
DB 2326 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 42. (a) Fluorescence titration of a 1µM DB 2326 with 5’-AAAATTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 306 
nm was used. The titration was run with an excitation slit width of 5 nm and an emission slit width of 5 nm. 
The black line indicates free compound while the blue line shows a 1:1 concentration ratio of 5’-
AAAATTT-3’. DB 2326 showed little inherent fluorescence. Addition of DNA resulted in an increase in 
fluorescence up to 0.6:1; however, the fluorescence began to decrease at a 0.8:1 ratio (DNA to compound). 
(b) Chemical structure of DB 2326.  
DB 2326 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 43. (a) Fluorescence titration of a 1µM DB 2326 with 5’-AAAGTTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 306 
nm was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 10 
nm. The black line indicates free compound while the blue line shows a 1:1 ratio of 5’-AAAGTTT-3’. 
Initially, addition of DNA displayed a large increase in fluorescence; however, fluorescence began to 
decrease at a 0.4:1 ratio of DNA to compound. (b) Chemical structure of DB 2326.  
DB 2348 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 44. (a) Fluorescence titration of a 1µM DB 2348 with 5’-AAAATTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 305 
nm was used. The titration was run with an excitation slit width of 5 nm and an emission slit width of 5 nm. 
DB 2348 showed little inherent fluorescence; however, upon binding with DNA, the fluorescence intensity 
increased. Upon reaching a concentration ratio of 0.6:1 (DNA to compound), fluorescence intensity 
decreased. (b) Chemical structure of DB 2348.  
DB 2348 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 45. (a) Fluorescence titration of a 1µM DB 2348 with 5’-AAAGTTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 305 
nm was used. The titration was run with an excitation slit width of 5 nm and an emission slit width of 5 nm. 
DB 2348 showed little inherent fluorescence; however, upon binding with DNA, fluorescence increased. 
Initial titrations of DNA showed a marked increase in fluorescence intensity but upon reaching a 0.6:1 ratio 
of DNA to DB 2348, fluorescence intensity became stagnant. (b) Chemical structure of DB 2348.  
DB 2350 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 46. (a) Fluorescence titration of a 1µM DB 2350 with 5’-AAAATTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 304 
nm was used. The titration was run with an excitation slit width of 5 nm and an emission slit width of 5 nm. 
DB 2350 showed little to no inherent fluorescence; however, upon binding with DNA, the fluorescence 
intensity increased. (b) Chemical structure of DB 2350.  
DB 2350 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 47. (a) Fluorescence titration of a 1µM DB 2350 with 5’-AAAGTTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 304 
nm was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 10 
nm. DB 2350 showed little inherent fluorescence; however, upon binding with DNA, the fluorescence 
intensity increased. (b) Chemical structure of DB 2350.  
DB 2351 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 48. (a) Fluorescence titration of a 1µM DB 2351 with 5’-AAAATTT-3’. The titration was carried 
out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation wavelength of 302 
nm was used. The titration was run with an excitation slit width of 10 nm and an emission slit width of 5 
nm. Fluorescence intensity increased to a concentration ratio of 0.6:1 (DNA to compound) followed by a 
slight decrease in the intensity with higher ratios. (b) Chemical structure of DB 2351.  
DB 2351 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 49. (a) Fluorescence titration of a 1µM DB 2351 with 5’-AAAGTTT-3’. The titration was 
carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer, at pH 7.4. An excitation 
wavelength of 302 nm was used. The titration was run with an excitation slit width of 5 nm and 
an emission slit width of 5 nm. Fluorescence intensity maximum for DB 2351 experienced a blue 
shift upon increasing DNA concentrations and continued to decrease upon each addition of 
DNA. (b) Chemical structure of DB 2351.  
4.4.3 Circular Dichroism  
DB 2326 Titrated with 5’-AAAATTT-3’  
 
 
Figure 50. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2326. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Small increase shifts in the 300 nm region suggest that DB 2326 binds weakly in the minor groove. 
The DNA may experience some microstructural changes upon binding, as represented by the CD changes 
as shown below 300 nm. (b) Chemical structure of DB 2326. 
DB 2326 Titrated with 5’-AAAGTTT-3’  
 
 
Figure 51. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2326. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Little induced CD changes in the 300 nm region suggest that DB 2326 binds weakly in the DNA minor 
groove. Microstructural changes in the DNA may occur upon binding as represented in the region below 
300 nm. (b) Chemical structure of DB 2326. 
DB 2348 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 52. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2348. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Changes in the 300 nm region suggest that DB 2348 binds in the DNA minor groove. Microstructural 
changes in the DNA may occur as represented by the changes observed in the region between 250 and 300 
nm. (b) Chemical structure of DB 2348. 
DB 2348 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 53. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2348. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. DB 2348 likely binds weakly in the minor groove of DNA as indicated by subtle changes in the 300 
nm region. The DNA microstructure may experience a change upon binding of DB 2348 as represented by 
variations in the induced CD curves in the region below 300 nm. (b) Chemical structure of DB 2348. 
 
DB 2350 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 54. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2350. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Weak binding of DB 2350 to the minor groove of DNA is suggested by subtle changes in the 300 nm 
region. The DNA microstructure may undergo some changes as represented by variations in the CD curve 
spectra below 300 nm. (b) Chemical structure of DB 2350. 
DB 2350 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 55. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2350. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. DB 2350 binding to the minor groove of DNA likely occurs weakly as indicated by the subtle CD 
changes in the 300 nm region. DNA microstructure may experience a change upon binding at high 
concentration ratios (compound to DNA) as represented by variations in the spectral region below 300 nm. 
(b) Chemical structure of DB 2350. 
DB 2351 Titrated with 5’-AAAATTT-3’ 
 
 
Figure 56. (a) Circular dichroism results of 5’-AAAATTT-3’ titrated with DB 2351. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Minor changes in the CD 300 nm region suggest DB 2351 binds weakly to the minor groove of DNA. 
The DNA microstructure may undergo some change at high compound concentrations, as represented by 
variations in the titration curves below 300 nm. (b) Chemical structure of DB 2351. 
DB 2351 Titrated with 5’-AAAGTTT-3’ 
 
 
Figure 57. (a) Circular dichroism results of 5’-AAAGTTT-3’ titrated with DB 2351. DNA concentration 
was 3 µM. The titration was carried out in a 50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA buffer at pH 
7.4. Binding of DB 2351 to the minor groove of DNA is suggested based on changes in the 300 nm region. 
Microstructural changes in the DNA may occur upon addition of DB 2351 as represented by variations in 
the spectral region below 300 nm. (b) Chemical structure of DB 2351. 
5. Results 
5.1 Structure Comparison  
From previously synthesized compounds by the Boykin laboratory, three groups of minor 
groove binders were selected for investigation using spectroscopic techniques. Each of these small 
molecules was designed from established modules to target specific sequences in DNA for possible 
use as therapeutics. Specifically, these modules are known components of minor groove binders 
that recognize AT tracts7. Using these structures as building blocks, efforts were taken to modify 
the selectivity by adding various functional groups and linkers to target sequences that contain GC 
base pairs7. The selection of molecules for this study was made based on structurally similar 
elements that could be easily studied using spectroscopic techniques. The core group of 
compounds consists of DB 2363, DB 2364, DB 2324 and DB 2368. DB 2363 is comprised of a 
benzimidazole moiety with an amidine at position 5 and amide at position 2. DB 2364 has the 
same moiety and attached functional groups as DB 2363 but the benzimidazole has been 
methylated at position 3. DB 2324 has a 7-azabenzimidazole as its primary moiety with a 
benzamide at position 2, similar to DB 2363 and DB 2364. At position 6, this molecule has an 
alkyl ether linker to a benzamidine. DB 2368 contains both a 7-azabenzimidazole and a 
benzimidazole joined at the 2 position of benzimidazole and the 6 position of 7-azabenzimidazole. 
At position 2 of the 7-azabenzimidazole, there is a phenol group and at position 6 of the 
benzimidazole there is an amidine. 
The second group of small molecules, Category 2 compounds, is a derivative of the core 
group containing DB 2309, DB 2325, DB 2327 and DB 2328. These molecules specifically differ 
in their central moiety. DB 2309 is a symmetric structure comprised of a two 2-para-benzamidine-
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4-methyl-thiazole linked at the 5 position of each thiazole. Similar to DB 2364, DB 2325 is also 
symmetric with 2 thiophenes linked at position 5. At, the 2 position of each thiophene, there is a 
1-methyl-5-amidino-benzimidazole. DB 2327 is structurally related to DB 2363 in that it has the 
same benzimidazole moiety with an amidine at position 5 and a phenyl group at position 2 and 
attached to the phenyl ring is a 2-amide-furan. DB 2328 differs from DB 2327 only by methylation 
at position 1 of benzimidazole, similar to the difference between DB2364 and DB 2363. 
The last category of minor groove binders investigated, Category 3 compounds, contains 
four Boykin compounds that are much larger than those in the previous two groups: DB 2326, DB 
2351, DB 2348 and DB 2350. Each of these structures is symmetric, only differing in the group 
joining the two symmetric terminal moieties. This moiety is a methylated benzimidazole with an 
amidine at position 5 and a phenyl ring at position 2. Linking each of these symmetric units to the 
central functional group are two alkyl ethers at the para position of the phenyl ring. The central 
functional group for DB 2326 is a pyridine. DB 2348 has a methyl-phenyl group as the central 
linker. The symmetric moieties in DB 2350 are separated by a tertiary amine. Similar to DB 2326, 
DB 2351 has a central pyridine. The difference lies in the symmetric unit with the incorporation 
of fluorine on the phenyl rings.  
To gain further understanding about the atomic detail of these compounds, all molecules 
were energy minimized using a Hartree-Fock approximation with a 6-31G* basis set. It can be 
seen that each structure adapts to a crescent like shape after minimization, which is characteristic 
of known minor groove binders. Longer linking units, such as alkyl ethers, increases the flexibility 
of the small molecules and allows for greater diversity in the crescent configuration. This can be 
seen in DB 2324, DB 2325 and DB 2348. The electrostatic potential surfaces were also calculated 
and show the characteristic positive electrostatic regions at the amide and amino groups, as well 
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as around the nitrogen atoms of azabenzimidazole and benzimidazole groups. Each of these 
regions provides a potential location for hydrogen bond interactions, which would further enhance 
minor groove binding. In the second group of groove binders, the incorporation of heterocycles 
provides additional hydrogen bond locations and increases the number of negative electrostatic 
potential sights.  
5.2 Category 1 Compounds 
For each small molecule, fluorescence and CD measurements were recorded for varying 
concentrations in solution with one of the two DNA sequences of interest. DB 2363 showed strong 
binding for both A4T3 and A3GT3 based on the fluorescence intensity indicating no sequence 
selectivity. The peak emission at 390 nm decreases as the concentration of DNA increases, 
indicating association between the small molecule and DNA sequence. This is supported by 
observations taken using CD spectroscopy. In the region of compound binding (> 300 nm), there 
are subtle fluctuations in the CD ellipticity indicting no structural changes in the conformation of 
DNA.  
DB 2364 also shows binding for both sequences in the fluorescence emission spectra with 
noticeable decreases in the peak emission at 395 nm with increasing DNA concentration. However, 
this is not supported by the observed CD spectra. There is no significant increase in ellipticity in 
the region above 300 nm with increasing concentration of the small molecule. This suggests 
limited changes in CD upon binding are occurring. In the region below 300 nm there are variations 
in peak ellipticity, which may indicate interaction with sequence A4T3. Therefore, DB 2364 has 
the potential to change the DNA structure of A4T3 but it may not be the result of minor groove 
binding. It is possible that the DB 2364 compounds area binding to the anionic DNA backbone 
and stacking on top of one another to form aggregates. The amide of DB 2364 has the potential to 
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form hydrogen bonds with the amide or amidine to stabilize dimers or multimers. This type of 
interaction is highly cooperative and is more favorable at higher concentrations of small molecule, 
which could explain the quenching seen in the fluorescence.  
The intensity of the maximum peak emission at 425 nm decreases with increasing DNA 
solution for sequences in the presence of DB 2324 for both sequences. However, there is a more 
substantial decrease in emission in the A3GT3 sequence indicating selectivity for the AAAGTTT 
sequence with quenching upon binding to the amino group of G. The emission spectrum for DB 
2324 in the presence of A4T3 is blue-shifted. This type of hypsochromic shift is seen in 
intercalators specifically those that bind as multimers such as the mutagenic agent24,25. It is possible 
that more than one DB 2324 is interacting with the minor groove of the A4T3 sequence. The CD 
spectrum for DB 2324 also shows a preference for A3GT3 with a noticeable change in ellipticity 
at 325 nm. Additionally, there are some changes in ellipticity observed in the region below 300 
nm, which may correlate to microstructural changes in the A3GT3 sequence upon binding DB 
2324. These features, although present in the CD spectrum of DB 2324 in the presence of A3GT3 
are absent in the CD spectrum of A4T3.   
DB 2368 shows no sequence specificity and subtle changes in the fluorescence emission 
data; however, the CD shows a large peak ellipticity around 360 nm that would be indicative of 
strong binding for both sequences. The CD spectra of optically active compounds are directly 
correlated to their native absorbance. Therefore, in the vicinity of the absorption band, changes in 
the spectra that are not the result of structure can be seen11. This effect, is called the Cotton effect, 
will cause either positive or negative rotational changes in the CD spectrum around the maximum 
absorbance of the sample11. The strong ellipticity seen in the CD could be the result of a positive 
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Cotton effect due to absorption by the aromatic groups, which was observed at 356 nm. This would 
support the evidence seen in the fluorescence data indicating little to no binding.  
5.3 Category 2 Compounds 
The second group of molecules has an extended conjugated ring system and the effect it 
has on these chromophores is apparent in the fluorescence spectra. DB 2309 shows only one peak 
absorbance around 430 nm. It is the only compound that does not have a benzimidazole in this 
group and it is possible that this difference results in only one peak absorbance in the fluorescence 
spectrum. The fluorescence spectra of both sequences decrease with increasing amount of DNA 
indicating minor groove binding for both sequences. In the CD spectra, very small changes in the 
300 to 350 nm region indicate that DB 2309 is weakly interacting with the minor groove.   
DB 2325 shows two characteristic emission peaks: one at 455 nm and another at 485 nm. 
The fluorescence for each sequence shows increasing intensity with the addition of DNA 
indicating minor groove binding. In the CD spectra of both sequences there is a clear and 
distinctive decrease in ellipticity around 425 nm. This indicates possible intercalation upon 
binding. Additionally, there are changes in ellipticity around 280 nm indicating that the small 
molecule may influence the microstructure of both DNA sequences upon association.   
DB 2327 shows a strong preference for A4T3 in the fluorescence data with two 
characteristic peaks: one at 380 nm and a second at 400 nm. There is a clear increase in 
fluorescence with increasing concentrations of DNA. On the other hand, DB 2327 only shows 
weak binding with A3GT3. No clear trend in emission and concentration is observed. Similar to 
the CD spectra of DB 2325, the ellipticity decreases above 300nm indicates possible intercalation 
with both sequences. The observed ellipticity could be the result of a negative Cotton effect at 345 
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nm, the same wavelength of observed absorption. In addition to the negative amplitude above 400 
nm, there is strong increase in amplitude in the 300 nm range, which could indicate changes in the 
DNA microstructural conformation.  
DB 2328 has two peak emissions at 380 nm and 400 nm similar to DB 2327. The 
fluorescence decreases with increasing concentration of A3GT3.  In the fluorescence titration of 
DB 2328 with A4T3, however, the emission increases with in increasing concentration of DNA. 
The decrease in fluorescence seen in the DB 2328 A3GT3 could indicate DNA minor groove 
binding. In contrast, hyperchromism seen in the titration of DB 2328 with A4T3 could indicate 
damage to the DNA double-helix structure. DB 2328 shows preferential binding to A3GT3 in 
contrast to the fluorescence titration with A4T3. This is supported by the CD spectrum. There is 
clear increase in amplitude of ellipticity at approximately 350 nm in the region of minor groove 
binding with A3GT3. Also, there are possible conformational changes in the DNA microstructure, 
as observed below 300 nm. For the A4T3 sequence, there is limited variance in the ellipticity above 
300 nm and large variation in ellipticity below 300 nm. This supports the fluorescence data 
indicating possible structure degradation.  
5.4 Category 3 Compounds  
The small molecules that belong to Category 3 are larger than those in Categories 1 and 2. 
The effect of this change in size is a decrease in binding observed with both sequences in all four 
compounds. The fluorescence spectra of DB 2326 shows limited binding to both A4T3 and A3GT3 
with slightly better results seen with A3GT3. This is supported by the CD spectra, which are almost 
superimposable. The only difference is in minor conformational shifts seen around 275 nm for the 
A3GT3 sequence. DB 2348 shows similar weak binding as DB 2326. Overall, there is binding for 
both sequences but possibly a slight preference for A3GT3. The CD supports this observation with 
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weak microstructural changes seen in lower wavelengths in the A3GT3 sequence and possible 
binding around 325 nm. DB 2350 shows no changes with A4T3 or A3GT3 in either fluorescence 
or CD spectra. DB 2351 is the only small molecule in this category that shows a strong possibility 
of binding to either sequence. Specifically, the fluorescence spectrum of DB 2351 in association 
with A3GT3 shows two peaks at 340 nm and 410 nm that decrease with increasing DNA 
concentration. Based on the CD for the A3GT3 sequence, there appears to be a slight increase in 
ellipticity at 320 nm indicating possible minor groove binding. The CD also shows similar changes 
in the region below 300 nm, which may correlate to distortions in the DNA microstructure once 
DB 2351 binds in the minor groove. 
6. Discussion 
The primary goals of this research were the determination of absorption, fluorescence and 
circular dichroism spectral properties for three groups of selected minor groove binders in the 
presence of two DNA sequences and the analysis of computational calculations and electrostatic 
potentials of the unbound conformations. Both spectroscopic and computational calculations led 
to further insight into the compound-DNA complexes and binding strategies.  
 Two DNA sequences, 5’-AAAATTT-3’ (A4T3) and 5’-AAAGTTT-3’ (A3GT3), were 
used in order to better determine sequence specificities. In addition to the two DNA sequences, 
three groups of minor groove binders were selected from previously synthesized Boykin 
compounds. Using spectroscopic techniques and computational calculations, modifications in the 
minor groove binders can be related to sequence selectivity.   
 The core group of compounds comprised of DB 2363, DB 2364, DB 2324 and DB 2368 
contains a central benzimidazole with small derivations. Both DB 2363 and DB 2364 show 
potential binding for both A4T3 and A3GT3 based on the observed emission spectra. This is 
confirmed for DB 2363 in the CD spectra, but not for DB 2364, which shows no minor groove 
binding peak above 300 nm. Observing the minimized structure for both of these compounds, it 
would appear that both compounds would bind similarly. The only difference is a methyl group at 
the 1 position of DB 2364. The possible effect of this methyl group is that it does not fit in the 
minor groove and distorts the DNA structure. Evidence of this can be seen in the CD spectra for 
both A4T3 and A3GT3 in the presence of DB 2364 below 300 nm. DB 2324, an azabenzimidazole 
groove binder, shows indication of minor groove binding to both A4T3 and A3GT3 sequences. 
This is supported by the decrease of emission intensity in the fluorescence for both sequences and 
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a slight peak above 300 nm in the CD. There appears to be a slight preference for A3GT3 with a 
stronger ellipticity seen in the CD spectrum. DB 2368, containing both an azabenzimidazole and 
a benzimidazole, shows no sequence specificity and subtle changes in the emission data. However, 
the CD shows a large peak ellipticity around 360 nm, which would be indicative of strong binding 
for both sequences.   
 The second category includes DB 2309, DB 2325, DB 2327 and DB 2328 with unique 
heterocycles incorporated as central moieties or linkers. DB 2309 shows evidence of minor groove 
binding for both sequences in the fluorescence data. The CD shows limited binding for A4T3 but 
some binding for A3GT3 indicating possible GC step targeting. The fluorescence intensity of DB 
2325 for each sequence shows increasing intensity with the addition of DNA indicating minor 
groove binding. Interestingly, in the CD spectra there is a clear and distinctive decrease in 
ellipticity around 425 nm. This indicates possible intercalation upon binding for this small 
molecule rather than the predicted minor groove binding. Observing the minimized structure and 
electrostatic potential map from the computational calculations, it is possible that one of the 
symmetric units intercalates, leaving the remaining portion of the small molecule solvent 
accessible. DB 2327 shows a strong preference for A4T3 in the fluorescence data but there is no 
clear trend in emission in the presence of A3GT3. Similar to the CD of DB 2325, the ellipticity at 
345 nm indicates possible intercalation with both sequences. However, this could be the result of 
the Cotton effect given that the negative ellipticity occurs at the same wavelength of observed 
absorption. DB 2328 shows strong preferential binding to A3GT3, in contrast to the limited 
binding observed with A4T3 in the fluorescence emission spectrum. This is supported by the CD 
spectrum. In the CD spectrum of A3GT3 sequence, there is a clear increase in amplitude of 
ellipticity at approximately 350 nm in the region of minor groove binding. However, there are 
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distinct conformation changes in the DNA observed below 300 nm. This could be the result of the 
high degree of internal rotation between the phenyl ring and the benzimidazole as seen in the 
minimized structure of DB 2328.  
 The third group contains large, symmetric potential groove binders. DB 2326, DB 2351, 
DB 2348 and DB 2350 all have the same essential symmetric units but vary in their central linkers. 
The effect of this change in size results in a decrease in binding to both sequences. For DB 2326, 
DB 2348, DB 2350, and DB 2351, the fluorescence shows weak trends toward binding for both 
structures. This could indicate weak association of the DB compounds to both DNA 
microstructures. This is supported by the CD data. None of these structures show strong indication 
of minor groove binding to either sequence. In the region below 300 nm, there is evidence to 
suggest microstructural changes in the DNA sequences, further substantiating the idea that no 
minor groove binding is occurring. It is possible that these larger DB compounds require a longer 
DNA microseqeuence in order to probably study binding.   
7. Conclusion 
In this research, we have focused on the absorption, fluorescence, circular dichroism, 
electrostatic potentials and calculated minimized geometries of three groups of minor group 
binders in order gain further insight into minor groove binding with select sequences of DNA. 
Using both spectroscopic techniques and computational calculations, compounds that selectively 
target DNA have been studied in order to supply insight into potential, clinically beneficial 
therapeutics for genetic disorders. Cationic minor groove binders have been shown to be 
advantageous over intercalating agents because they can readily enter the cell nucleus, target 
specific DNA sequences and work allosterically with gene-control proteins26. Furthermore, minor 
groove binding drugs have been shown to have lower levels of toxicity7. Although a variety of 
these compounds have been produced and are now under study, much more information is still 
needed regarding binding strategies and sequence selectivity. 
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